Background
Syphilis, a Sexually Transmitted Disease (STD) caused by the bacterium Treponema pallidum, has affected humanity for centuries.1 Its treatment history epitomises the growth of medical knowledge, demonstrating the transition from ancient and often risky therapies to the invention of effective modern antibiotics. Understanding this process highlights not just breakthroughs in medical knowledge but also the need for ongoing research and public health initiatives in the global battle against infectious diseases.
Phases of Syphilitic infection
The infection progresses through four phases and can damage nearly all organ systems in the body, even many years after the initial infection.
- Primary
- Secondary
- Latent
- Tertiary
Unveiling the early history of Syphilis
Syphilis first emerged in Europe at the end of the fifteenth century and shortly thereafter became a major threat to public health. Theories regarding its origin varied, with some attributing it to explorers returning from the New World and others believing it existed undiscovered in Europe.2
Early symptoms included painful sores, rashes, and systemic illness, leading to devastating effects if not addressed.
Initially, diagnosis was rudimentary relying mostly on visible symptoms and patient history. Physicians and healers attempted a variety of remedies, most of which were ineffective and sometimes risky.
Mercury treatment: the renaissance and early modern periods
The initial major attempt to cure syphilis was the administration of mercury, which began at the end of the fourteenth century and lasted for a long time. Mercury was delivered via ointments, vapour baths, and oral ingestion.
Owing to the lethal properties of mercury, patients often experience significant side effects such as salivation, tooth loss, and brain damage.
Despite its risks, mercury was considered beneficial, partly because it caused excessive sweating and salivation, which were believed to eliminate the infection from the body.
Documents from this time indicate the reliance on mercury and the suffering it caused. Many patients experienced a major decline in health as a result of the treatment.3
Evolving treatments in the 18th and 19th centuries
As the potential hazards of mercury became more apparent, alternative treatments emerged. Herbal medicines, such as guaiacum, became popular, although their efficacy was limited.4 The advent of chemical alternatives such as iodine and bismuth in the nineteenth century was a significant advancement, offering simpler and safer alternatives to mercury.3
In 1909, Paul Ehrlich and Sahachiro Hata invented Salvarsan, also known as arsphenamine, which was one of the groundbreaking discoveries of the era. This molecular compound was the first modern chemotherapeutic drug, offering a more targeted and successful therapy for syphilis. Salvarsan significantly improved patient outcomes and was a turning point in the history of antimicrobial treatment.5
The penicillin revolution
Alexander Fleming discovered penicillin in 1928, revolutionising the treatment of bacterial infections such as syphilis. Primarily used to treat a variety of bacterial diseases, penicillin's potential for treating syphilis was discovered during clinical trials in the 1940s.6 Its capacity to efficiently treat syphilis with little adverse effects resulted in a substantial change in public health.
Penicillin became the gold standard for syphilis treatment, resulting in a dramatic drop in syphilis rates across the world. This time witnessed intensive public health efforts focused on informing the public and promoting treatment, which contributed to the decline in new infections.7
Modern antibiotic treatments
Today, penicillin G is the primary treatment for syphilis, particularly in the early stages. Alternative antibiotics, such as doxycycline and azithromycin, are used in individuals allergic to penicillin or who have penicillin-resistant strains.8
Modern therapy techniques include: (depending on the stage of the disease)
- Intramuscular injections
- Oral delivery
Despite these advancements, challenges persist. Antibiotic resistance is becoming a major concern, demanding constant research to develop novel therapeutics. Co-illnesses with other sexually transmitted infections further complicate therapy, demanding extensive treatment measures.9 Global health programmes prioritise expanding access to treatment and prevention measures, particularly in resource-constrained areas where syphilis remains prevalent.
Social and cultural impacts
The social and cultural impacts of syphilis therapy are significant. Syphilis has historically borne a high stigma, with many seeing it as a sign of immorality. This stigma hampered initiatives to seek treatment and raised public health concerns. Over time, public health campaigns attempted to minimise this stigma by promoting education and raising awareness to support prevention and treatment.10
Ethical concerns around syphilis treatment have also evolved. Notable historical breaches, such as the infamous Tuskegee Syphilis Study, highlighted the value of ethical standards in medical research and treatment.11 Modern techniques emphasise patient consent, openness, and equitable access to care.
FAQs
Are there any traditional or folk remedies used to treat syphilis?
Yes, various traditional and folk treatments have been used throughout history. These included herbal medicines, such as guaiacum, and traditional cures employed by Native American tribes. These medicines, however, were far less effective than current antibiotics.
What were the major drawbacks of early syphilis treatments?
Early treatments, especially those using mercury, were extremely harmful. Patients frequently reported severe side effects such as mouth ulcers, tooth loss, and brain impairment. Despite its toxicity, mercury has been used for centuries due to a lack of safer alternatives.
How did the discovery of penicillin revolutionise syphilis treatment?
In 1928, Alexander Fleming discovered penicillin, which revolutionised syphilis treatment. Penicillin was discovered in the 1940s to be highly effective against Treponema pallidum, facilitating a reasonably safe and successful treatment for syphilis. This was a significant turning point in the management of disease.
Summary
Syphilis treatment has advanced significantly, from the risky and frequently ineffective procedures of the past to the highly effective antibiotic treatments available today. This voyage represents the evolution of medical understanding, emphasising the importance of ongoing research and innovation in the battle against infectious illnesses. As we look ahead, our mission continues to improve therapies, address challenges, and ultimately eradicate syphilis as a public health threat.
References
- Ke W, Ao C, Wei R, Zhu X, Shui J, Zhao J, et al. Evaluating the clinical utility of semi-quantitative luciferase immunosorbent assay using Treponema pallidum antigens in syphilis diagnosis and treatment monitoring. Emerg Microbes Infect [Internet]. [cited 2024 June 1]; 13(1):2348525. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11100446/.
- Mitjà O, Padovese V, Folch C, Rossoni I, Marks M, Rodríguez I Arias MA, et al. Epidemiology and determinants of reemerging bacterial sexually transmitted infections (STIs) and emerging STIs in Europe. The Lancet Regional Health - Europe [Internet]. 2023 [cited 2024 June 3]; 34:100742. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2666776223001618.
- Syphilis - Its early history and Treatment until Penicillin and the Debate on its Origins. JMVH [Internet]. [cited 2024 June 6]. Available from: https://jmvh.org/article/syphilis-its-early-history-and-treatment-until-penicillin-and-the-debate-on-its-origins/.
- Tampa M, Sarbu I, Matei C, Benea V, Georgescu S. Brief History of Syphilis. J Med Life [Internet]. 2014 [cited 2024 June 7]; 7(1):4–10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956094/.
- Christensen SB. Drugs That Changed Society: History and Current Status of the Early Antibiotics: Salvarsan, Sulfonamides, and β-Lactams. Molecules [Internet]. 2021 [cited 2024 Jun 10]; 26(19):6057. Available from: https://www.mdpi.com/1420-3049/26/19/6057.
- Tan SY, Tatsumura Y. Alexander Fleming (1881–1955): Discoverer of penicillin. Singapore Med J [Internet]. 2015 [cited 2024 Jun 11]; 56(7):366–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520913/.
- Gaynes R. The Discovery of Penicillin—New Insights After More Than 75 Years of Clinical Use. Emerg Infect Dis [Internet]. 2017 [cited 2024 Jun 11]; 23(5):849–53. Available from: http://wwwnc.cdc.gov/eid/article/23/5/16-1556_article.htm.
- Mi H-F, Shen X, Chen X-Q, Zhang X-L, Ke W-J, Xiao Y. Association between treatment failure in patients with early syphilis and penicillin resistance-related gene mutations of Treponema pallidum: Protocol for a multicentre nested case–control study. Front Med [Internet]. 2023 [cited 2024 Jun 12]; 10. Available from: https://www.frontiersin.org/articles/10.3389/fmed.2023.1131921.
- Choudhry S, Ramachandran VG, Das S, Bhattacharya SN, Mogha NS. Characterization of patients with multiple sexually transmitted infections: A hospital-based survey. Indian J Sex Transm Dis AIDS [Internet]. 2010 [cited 2024 Jun 15]; 31(2):87–91. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122591/.
- Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019; 97(8):548-562P. Available from: https://pubmed.ncbi.nlm.nih.gov/31384073/
- African American Heritage. National Archives [Internet]. 2016 [cited 2024 Jun 15]. Available from: https://www.archives.gov/research/african-americans.
Appendices
- Sexually Transmitted Diseases: To know more! https://www.ncbi.nlm.nih.gov/books/NBK560808/
- Data on syphilis [cited 2024 Jun 10]. Available from: https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/data-on-syphilis
- Fleming, A. (1929). On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. British Journal of Experimental Pathology, 10(3), 226-236. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2048009/
- Syphilitic city story: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349077/

